This prolonged presence is actually beneficial for treatment adherence, as it allows for once-weekly dosing rather than daily injections
JBMR Plus 2(3):121133 [DOI] [PMC free article] [PubMed] [Google Scholar] 11.Lindeman KG, Greenblatt LB, Rourke C et al (2018) Longitudinal 5-year evaluation of bone density and microarchitecture after Roux-en-Y gastric bypass surgery
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Short-acting GLP-1RAs, such as lixisenatide, maintain robust effects on gastric emptying, whereas long-acting agents, like liraglutide and semaglutide, exhibit reduced efficacy due to continuous receptor activation
Food and Drug Administration (FDA)
Cost per unit of weight loss Beyond efficacy, cost efficiency matters for researchers planning sustained protocols